Expert, Integrated Cell Therapy GMP Manufacturing
Cellipont Bioservices offers specialized cell therapy GMP manufacturing designed to advance novel therapies from concept to clinical evaluation with precision, speed, and compliance. With a purpose‑built facility, deeply experienced technical teams, and integrated end‑to‑end capabilities, we provide the foundation innovators need to bring life‑changing cell therapies to patients. Our services span early development, process optimization, technology transfer, cGMP manufacturing, analytical testing, and regulatory support, ensuring quality and continuity at every stage.
Our Cell Therapy Capabilities
At Cellipont, our capabilities are designed to accelerate the path from research to clinical impact—bringing together process development, cell therapy GMP manufacturing, quality control, and regulatory guidance under one coordinated program structure.
Technology Transfer & Lifecycle Management
We support seamless technology transfer from research settings into GMP environments. Whether scaling an early‑stage protocol or transferring an established production process, our team ensures:
- Full process comparability
- Document and method readiness
- Equipment compatibility assessments
- Gap analyses and risk mitigation
- Smooth transition into cGMP manufacturing
Our lifecycle management approach supports multiple clinical phases, allowing your program to evolve efficiently as regulatory and scale demands increase.
GMP & Regulatory Compliance
Quality and compliance are at the heart of Cellipont’s manufacturing philosophy. We adhere to the highest global standards, including:
- GMP (Good Manufacturing Practice):
Rigorous protocols for facility management, documentation, and process control. - FDA & EMA Compliance:
Our systems are designed to meet the requirements of major regulatory agencies, supporting global product registration and commercialization.
Our dedicated quality assurance team ensures every batch meets stringent specifications, giving clients confidence in product safety, efficacy, and regulatory readiness.
Our Manufacturing Facility
Our purpose-built GMP facility is designed to support a wide range of cell therapy modalities, with flexible, segregated environments that enable efficient scale‑up while maintaining strict control and compliance.
- Segregated manufacturing suites designed for autologous and allogeneic workflows
- Controlled sterile processing and fill/finish environments
- On‑site QC laboratories
- Scalable equipment platforms supporting clinical‑grade volumes
- A Ballroom‑style Flex Suite designed for emerging technologies, including exosomes
Why Choose Cellipont Bioservices
Choosing the right cell therapy GMP manufacturing partner is critical for the success of your cell therapy program. Here's why Cellipont stands out:
End‑to‑End Capabilities
A fully connected platform from development to GMP manufacturing.
Deep Scientific Expertise
Teams with decades of hands‑on cell therapy experience.
Flexible, Scalable Infrastructure
Purpose-built spaces tailored for multiple modalities.
Uncompromising Quality
Strong QA/QC frameworks and regulatory alignment at every step.
Client-Centric Collaboration
Transparent communication and shared decision‑making throughout your program.
What Our Clients Are Saying
"We sought a manufacturing partner with the capabilities to support not only mid‑to‑late‑stage clinical development but also future commercial production, and we believe Cellipont is well positioned to support us as we advance our program through the next stages."
"Cellipont brings deep technical capabilities and a shared sense of urgency to help us translate the promise of ERNA‑101 into a clinically viable therapy. This collaboration marks an important milestone in advancing our iMSC platform."
Our Cell Therapy Services
We support a wide range of therapeutic platforms:
Ready to take the next step in cell therapy manufacturing?
Connect with Cellipont Bioservices today and discover how our expertise can accelerate your program and deliver life-changing therapies to patients worldwide.
Let’s work togetherFAQs
Cellipont applies a fully integrated, end‑to‑end cell therapy platform that includes process development, analytical development, cGMP production, QC testing, documentation, and regulatory alignment, ensuring every program meets strict FDA, EMA, and ICH guidelines.
Cellipont provides flexible GMP manufacturing for both autologous and allogeneic cell therapies, supporting programs from early clinical development through commercial scale. Our capabilities include automated, fully closed manufacturing workflows, scalable equipment platforms, and multi-product GMP suites designed to ensure consistency, efficiency, and compliance. Purpose-built and modular facility design allows programs to evolve as batch size, throughput, and lifecycle demands increase.
We support a broad range of cell therapy technologies, including allogeneic, autologous, iPSC‑derived programs, gene‑modified products, NK cells, T‑cell subsets, and advanced platforms integrated across our facility and development labs.
Cellipont adheres to US and EU cGMP frameworks, maintains robust quality systems, employs comprehensive documentation and batch‑record processes, and performs method validation, stability programs, and continuous quality oversight to ensure regulatory readiness.
Tech transfer includes full process and analytical review, method transfer, gap assessments, equipment compatibility, engineering runs, documentation alignment, and readiness testing to ensure seamless movement into GMP manufacturing.
Our purpose‑built facility includes GMP cleanrooms, QC laboratories, warehousing, cryopreservation systems, environmental monitoring, and multi‑product manufacturing suites designed to meet global GMP operational readiness.